NSE filing, NSE: ANTHEM. Summary written from the filing by ALFA Finder's alert engine.
Anthem Biosciences Ltd: key numbers
- Share price
- ₹854.45
- Market cap
- ₹48,122 Cr
- Revenue (annual)
- ₹2,124 Cr
- Net profit (annual)
- ₹591.8 Cr
- P/E (TTM)
- 83.5×Sector 47.2×
- Promoter holding
- 71.40%-0.02% QoQ
- FII holding
- 3.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anthem Biosciences Ltd
All →Anthem Biosciences Investor Presentation: Key Takeaways
Q2FY27 revenue ₹5,940 Mn (+7.9% YoY), PAT ₹2,115 Mn (+21.9%), EBITDA margin 50.6% including ₹589 Mn other income. H1FY27 revenue fell 7.2%.
Anthem Biosciences Q2 FY27 Results: Net Profit ₹211.5 Cr, Up 22.0% YoY
Anthem Biosciences Ltd reported revenue from operations of ₹594 Cr (+7.9% YoY) and net profit of ₹211.5 Cr (+22.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹211.5 Cr · +22.0% YoY
Anthem Biosciences Board Meeting Date
Anthem Biosciences scheduled a Board meeting for November 3, 2026 to approve Q1 and H1 FY27 financial results. The trading window remains closed until November 5, 2026.
Anthem Biosciences Other Announcement
Anthem Biosciences Ltd has submitted its quarterly shareholding pattern as per SEBI regulations. The filing provides the current distribution of promoter and public shareholdings.
Anthem Biosciences Other Announcement
Designated Person Viridity Tone LLP sold shares of Anthem Biosciences Ltd worth ₹82.67 Crore via market sale.
- Value
- ₹82.67 Cr
Anthem Biosciences Legal & Regulatory
Anthem Biosciences Ltd announced the settlement of an upside sharing amount of ₹127.68 Crore related to a prior divestment, following shareholder approval.
- Value
- ₹127.7 Cr
Other results update announcements
All →V-Mart Retail Results Update
V-Mart Retail reported Q2 FY27 revenue of ₹953 crore, up 18%, and EBITDA of ₹86 crore, up 20%. Strong demand drove growth; festive timing shifted into Q3.
Inox India Results Update
INOX India's press release reported Q2 FY27 revenue of Rs.467 Crore, up 26.6% year-on-year, and PAT of Rs.66 Crore. Order backlog reached Rs.2,268 Crore, a company record.
Empower India Results Update
Empower India reported higher H1 FY27 consolidated income and standalone profit. It also signed a non-binding term sheet for Valiance Engineers.
Signpost India Results Update
Signpost India reported H1 FY27 results, with profit up 11% and operating cash flow tripling. Q2 revenue was flat as festive campaigns shifted to Q3.
GlaxoSmithKline Pharmaceuticals Results Update
GSK Pharmaceuticals reported Q2 FY27 media release showing revenue of INR 1180 crore (up 21%) and PAT of INR 335 crore (up 31%). The release also announces the upcoming BLENREP launch in India.
V2 Retail Results Update
V2 Retail issued a press release on its unaudited Q2 and H1 FY27 results. Revenue rose 42% in H1 to ₹1,902.8 crore, with EBITDA up 50%.